Sign Out
Prophylaxis of influenza, especially those who run an increased risk of
associated complications.
Influvac is indicated in adults and children from 6 months of age.
The use of Influvac should be based on official recommendations.
Vaccination is particularly recommended for the following categories
of patients, depending on national immunization policies: Persons aged ≥65 years, regardless their health condition.
Adults and children with chronic disorders of the pulmonary or cardiovascular systems, including asthma.
Adults and children with chronic metabolic diseases such as diabetes mellitus.
Adults and children with chronic renal dysfunction.
Adults and children with immunodeficiencies due to disease or immunosuppressant medication (e.g., cytostatics or corticosteroids) or radiotherapy.
Children and teenagers (6 months-18 years) who receive long-term acetylsalicylic acid containing medication and might therefore be at risk for developing Reye's syndrome following an influenza infection.
